Lelantos Holdings, Inc. (LNTO) Launches Fully Redesigned Website to Enhance Shareholder Transparency and Investor Access
TMX Newsfile· 2026-08-18 20:00
McAlester, Oklahoma--(Newsfile Corp. - August 18, 2026) - Lelantos Holdings, Inc. (OTCID: LNTO) ("Lelantos" or the "Company"), the parent company of Airtopia Adventure Parks, today announced the launch of its completely redesigned corporate website, lelantosholdings.io. The new platform reflects the Company's ongoing commitment to shareholder transparency and is designed to give current and prospective investors easier, more comprehensive access to the information they need to evaluate Lelantos' business, ...
The RoyaLand Company Ltd. Announces Unaudited Fiscal 2026 First Half Financial Results Including Proforma Combined with Recently-Acquired Italian Pro Football Club Savoia FC
Globenewswire· 2026-08-18 20:00
NAPLES, Italy and HAMILTON, Bermuda, Aug. 18, 2026 (GLOBE NEWSWIRE) -- The Royaland Company Ltd. (the “Company” or “RoyaLand”) (OTCQB: RLNDF), a Bermuda holding company focused on creating an online and offline immersive, fantasy-based royalty-themed game called TheRoyal.Land as well as ownership and growth of its Italian professional football club Savoia 1908 FC (“Savoia FC”), today announced its unaudited and proforma combined financial results for the first half of its 2026 fiscal year, the six months en ...
Is $2.5M Enough to Spend $100K a Year in Retirement, Or Will Taxes Leave Me Short?
Yahoo Finance· 2026-08-18 20:00
A $2.5 million portfolio could support $100,000 in annual retirement spending, but taxes might require you to withdraw more than that amount. Account type determines the portion of each distribution you keep. Knowing that amount can help you estimate whether your spending goal is sustainable and what adjustments you may need to make. How Much Do You Need to Withdraw to Spend $100,000? The 4% rule is a common benchmark that retirees use to estimate how much they can withdraw from their savings each yea ...
Zscaler and Carahsoft Expand Partnership to Deliver Enterprise-Proven Zero Trust Security to SMB and Mid-Market Customers
Globenewswire· 2026-08-18 20:00
核心观点 - Zscaler与Carahsoft扩大合作,通过Carahsoft的分销网络将Zscaler Zero Trust Exchange平台推向美国SMB和中端市场,提供针对成长型企业优化的企业级零信任安全解决方案 [1] 合作背景与市场机遇 - SMB和中端市场面临与大型企业相同的勒索软件、钓鱼和基于身份的网络威胁,但安全团队缺乏应对资源 [2] - 该细分市场运营模式日益分布式,依赖SaaS和云连接,安全需求迫切但资源受限 [2] - 合作通过Carahsoft的广泛分销网络和现有经销商关系,解决该细分市场的威胁和资源限制问题 [2] 合作内容与标准化方案 - 推出标准化客户方案:包含精选的Zero Trust Exchange捆绑包和部署加速器,旨在快速实现价值并降低运营负担 [6] - 简化消费模式:提供可预测、规模适中的定价和包装,匹配SMB预算,并通过Carahsoft经销商生态系统简化采购流程 [6] - 合作伙伴赋能规模化:提供可重复的入门手册、参考架构和支持对齐,使合作伙伴能无缝服务SMB市场 [6] - 市场推广伙伴加速:统一营销活动和联合销售框架,加速渠道参与和市场执行 [6] 高管观点 - Zscaler全球合作伙伴生态系统高级副总裁Anthony Torsiello表示,SMB和中端市场需要简单、快速和经济可预测的模型,扩大合作使平台更易触及该细分市场 [3] - Carahsoft总裁Craig P. Abod表示,通过结合Zscaler云安全平台与Carahsoft的经销商生态系统和渠道专长,可帮助合作伙伴加速采用、简化购买流程并交付长期价值 [3] 技术价值主张 - 用统一的云交付零信任模型取代传统安全堆栈和基于设备的架构,可消除隐式信任、保护远程用户和数据,并降低总拥有成本 [3] 公司概况 - Zscaler (NASDAQ: ZS) 是AI时代网络安全平台,其Zero Trust Exchange平台基于SASE架构,是全球最大的在线云安全平台,分布在160多个公共交易所和数千个边缘私有交易所 [4] - Carahsoft是可信IT解决方案提供商,服务于私营部门、企业、SMB、医疗保健和公共部门市场,作为Master Aggregator提供网络安全、人工智能、多云、DevSecOps等解决方案 [5]
Entera Appoints Global Pharmaceutical Leader Riccardo Paolo Camisasca, M.D., as Chief Medical Officer Ahead of Planned EB613 Phase 3 Initiation
Globenewswire· 2026-08-18 20:00
核心观点 - Entera Bio任命Riccardo Paolo Camisasca博士为首席医学官,以加强其临床执行团队,为计划中的EB613三期临床试验做准备[1] 高管任命与背景 - Dr Camisasca拥有超过30年全球制药研发和临床开发经验,曾任职于Sumitomo Pharma、Takeda和Novartis[1] - 他最近担任Sumitomo Pharma Switzerland的全球研发负责人,领导了Urovant、Enzyvant、Altavant和Myovant四个研发组织的整合,负责临床开发、全球试验执行和战略联盟管理[2] - 此前他在Bial领导临床开发和医学事务部门,管理约90人团队[2] - 他还曾在Syneos Health、Takeda和Novartis担任过一系列职责递增的职位[2] - 职业生涯早期,他在米兰San Raffaele医院担任医生和研究员约10年,从事内分泌和代谢疾病研究[2] - 他以优异成绩获得医学学位,并在米兰大学专攻临床药理学[2] 公司战略与管线进展 - CEO Miranda Toledano表示,Dr Camisasca的任命进一步加强了临床领导力,公司正过渡到后期临床执行阶段并推进更广泛的口服肽管线[2] - Dr Camisasca认为Entera已到达重要转折点,拥有稀缺的口服肽平台和潜在变革性资产EB613[2] - EB613是首个口服每日一次合成代谢片剂治疗骨质疏松症的药物[3] - 公司已完成一项161名患者的二期、6个月、安慰剂对照研究,该研究达到了所有生物标志物和骨密度(BMD)终点,且无显著安全性问题[3] - EB613产生了骨形成生化标志物的快速剂量依赖性增加、骨吸收标志物减少,以及腰椎、全髋和股骨颈BMD的增加[3] - 使用3D-DXA显示EB613在多种指标上相比安慰剂有增加,包括整体体积BMD、小梁体积BMD、皮质厚度和皮质表面BMD[3] - 数据与已发表的皮下特立帕肽在6个月时间点的数据一致[3] - 公司还开发首个口服长效PTH(1-34)片剂用于甲状旁腺功能减退症(EB612)、首个口服氧调节素(双靶向GLP1/胰高血糖素肽片剂)用于肥胖和代谢综合征,以及与OPKO Health合作开发首个口服GLP-2片剂用于短肠综合征[5] 技术平台 - 公司利用其专有N-Tab®技术平台,开发首创口服肽项目[5]
Applied Energetics Selected for Department of the Air Force Strategic Funding Increase
Accessnewswire· 2026-08-18 20:00
TUCSON, AZ / ACCESS Newswire / August 18, 2026 / Applied Energetics, Inc. (OTCQB:AERG), a leader in ultrashort pulse laser and directed energy technologies, today announced Applied Energetics has been selected for a Strategic Funding Increase (STRATFI) opportunity by AFWERX, the innovation arm of the Department of the Air Force and a directorate within the Air Force Research Laboratory, with potential funding of up to $4 million and additional potential funding of up to $4 million in matching funding from t ...
Nuclear Innovator Deep Isolation to Present at EnerCom Denver and OTC Markets Virtual Investor Conference in August
Globenewswire· 2026-08-18 20:00
Company Leadership to Update Institutional and Retail Investors at Two Upcoming EventsBERKELEY, Calif., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Deep Isolation Nuclear, Inc. (OTCQB: DBHL) (“Deep Isolation” or the “Company”), a leading innovator in nuclear waste disposal technology, today announced that the Company will participate in two upcoming investor conferences this month: the 31st annual EnerCom Denver Energy Investment Conference, and OTC Markets Group’s Virtual Investor Conference. Deep Isolation will pre ...
Earnings live updates: Klarna stock plunges on trimmed guidance, Home Depot gains
Yahoo Finance· 2026-08-18 19:59
零售业财报与消费者健康状况 - 本周零售业财报将检验消费者健康状况,随着第二季度财报季接近尾声 [1] - 家得宝(HD)业绩显示消费者继续支出,但偏向小型项目,因地缘政治担忧和通胀影响美国家庭 [1] - 沃尔玛(WMT)、塔吉特(TGT)和劳氏(LOW)等其他大型零售商也将在本周公布财报 [1] 整体财报季表现 - 整体财报季表现强劲,根据FactSet数据,标普500公司第二季度盈利同比增长50%,为2021年以来最高增长率 [2] - 美国银行策略师指出,人工智能是这一广泛盈利增长的引擎 [2]
Sea Ray parent Brunswick bets on AI navigation and new revenue streams to help stalling boat sales
CNBC· 2026-08-18 19:59
公司核心战略 - Brunswick公司正押注先进技术(如高级导航技术和自动停泊系统)以应对销售停滞问题[1] - 公司策略包含双重目标:一是吸引买家进入持续低迷的市场(新船零售预计疲软至2026年),二是通过技术和软件销售增加售后及经常性收入[2] 业务结构与收入来源 - Brunswick业务范围远超船艇品牌,旗下Navico Group销售船舶电子与技术,Mercury Marine供应发动机并经营零部件及配件业务[2] - 公司约60%的收益来自售后市场或经常性收入,Roth Capital Partners分析师Scott Stember指出这一组合使公司在新船销售之外拥有显著敞口[3] 市场展望与销售预测 - Brunswick向投资者预计到2030年年度销量将达到145,000至160,000艘,Roth将此描述为从今年美国零售预估销量(低于135,000艘)中的温和复苏[3] - 需求疲软在Brunswick最便宜的型号上感受最为明显[3] 产品表现分化 - CEO David Foulkes向CNBC表示,高端船艇及核心产品组合表现出很强的韧性,而价值型船艇(通常依赖融资或更易受利率压力影响)表现虽不算差,但不如高端产品[4]
Analyst issues new Micron stock price target
Finbold· 2026-08-18 19:58
美光科技投资评级与盈利展望 - 美银证券重申对美光科技(NASDAQ: MU)的“买入”评级,维持1550美元的目标价,较最新收盘价1011美元有约48%的上涨空间[1] - 该评级紧随美光被纳入美银美国1号名单,反映市场对内存行业进入更持久阶段、长期盈利潜力增强的信心增强[3] - 美银认为美光的盈利前景由内存市场的结构性变化支撑,而非传统的繁荣-萧条周期[3] - 美银强调行业供应增长更趋纪律性、客户承诺更强,这些因素可支撑持续盈利能力和更高的长期盈利水平[4] - 美银引用与SK海力士近期分析师活动相似的假设,认为美光最终每股收益可能超过230美元[4] - 在此框架下,美光2030财年每股收益预计在200至250美元之间,2026至2030财年每股收益年增长率超过30%[5] - 上述预测远高于华尔街当前预期,后者普遍预测未来一至两年峰值每股收益约160至170美元[6] 华尔街整体观点 - 根据TipRanks数据,30位分析师覆盖美光股票,其中29位给予“买入”评级,1位给予“持有”评级,形成“强烈买入”共识[6] - 美光12个月平均目标价为1568.39美元,较近期交易水平约有55%上涨空间[7] - 分析师最高目标价为2200美元,最低目标价为1100美元[7] - 美银保持对这家半导体公司较为看好的展望之一,投资者关注内存市场改善能否转化为持续盈利增长并支撑更高估值[7]